Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2007-04-24
2007-04-24
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S217000, C544S220000
Reexamination Certificate
active
10985236
ABSTRACT:
The present invention provides novel processes and intermediates for preparing corticotropin releasing factor (CRF) receptor antagonists having the structure below which are useful in treating CRF-related disorders such as anxiety and depression
REFERENCES:
patent: 3910907 (1975-10-01), O'Brien et al.
patent: 4824834 (1989-04-01), Fujii et al.
patent: 4892576 (1990-01-01), Kriiger et al.
patent: 5137887 (1992-08-01), Hashimoto et al.
patent: 5484760 (1996-01-01), Bussler et al.
patent: 6060478 (2000-05-01), Gilligan et al.
patent: 6124289 (2000-09-01), He et al.
patent: 6136809 (2000-10-01), Gilligan et al.
patent: 6191131 (2001-02-01), He et al.
patent: 6271376 (2001-08-01), Saikali et al.
patent: 6313124 (2001-11-01), He et al.
patent: 6358950 (2002-03-01), He et al.
patent: 6716981 (2004-04-01), Saikali et al.
patent: 2003/0125330 (2003-07-01), Gilligan
patent: 1 088 574 (1994-06-01), None
patent: 0 269 859 (1988-06-01), None
patent: 0 594 149 (1994-04-01), None
patent: 2001-302658 (2001-10-01), None
patent: WO 98/03510 (1998-01-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 01/23388 (2001-04-01), None
patent: WO 02/72202 (2002-09-01), None
Logemann, W., et al., “Studien in der heterocyclischen reihe, II. Mitteil.*): Die synthese von 1.3.5-triazine und 5-oxy-isoxazol-derivaten,”Chem. Ber., 1954, 87, 1175-1179 (German).
Bellec, C., et al., “Structure de derives de β- cétonitriles. II. Tautomérie hydrazone-énehydrazine; etude des configurations,”Beilstein Institut. Zur Foerderung Der, Accession No. 3384927, 1988, II-441-II-448 (Summary in English).
Souchay, et al., “CHDCAQ,”S.R.Hebd. Seances Acad. Sci. Ser. C, 1973, p. 1457 (Accession No. 2981462, 1 page).
Yamashita, M., “BCSJA8,” Bull. Chem. Soc. Jpn., 1941, 16, 413-415 (Accession No. 3384927, 1 page).
Albert, A.H., et al., “Synthesis of 2,4-dimethylpyrazolo[1,5-a]-1,2,5-triazine,”J. Het. Chem., 1973, p. 885.
Battaglia, G., et al., “characterization of corticotrophin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system,”Synapse, 1987, 1, 572-581.
Beyer, H., et al., “Zur umsetzung von ketonitrilen mit hydrazinderivaten der kohlensäure,”Verlag Chemie GMBH Weinheim/Bergstr.,, 1960, 9, 2209-2216.
Boissier, J.-R., et al., “A new method for rapid screening of minor transquillizers in mice,”Eur. J. of Pharmacol., 1968, 4, 145-151.
Bruni, F., et al., “Reactivity of 7-(2-dimethylaminovinyl)pyrazolo[1,5-a]pyrimidines: synthesis of pyrazolo[1,5-a][3,4-e]pyrimidine derivatives as potential benzodiazepine receptor ligands. 2.,”J. Heterocycl. Chem., 1995, 32, 291-298.
Collington, E.W., et al., “A facile and specific conversion of allylic alcohols to allylic chlorides,”J. Org. Chem., 1971, 36(20), 3044-3196.
Crossland, R.K., et al., “A facile synthesis of methanesulfonate esters,”J. Org. Chem., 1970, 35(9), 3195-3196.
Cusmano, S., et al., “Comportamento dei legami lidenici verso alcuni reattivi. Struttura delle sostanze ottenute per azione della semicarbazide sui benzalderivati di corpi β-chetonitriliei—Nota V.,”Gazz. Chim. Ital., 1952, 82, 373-384 (Italian).
Dunn, A.J., et al., “Physiological and behavioral responses to corticotrophin-releasing factor administration: is CRF a mediator of anxiety or stress responses,”Brain Res. Rev., 1990, 15, 71-100.
Funk, D., et al., “Role of catecholamines in the frontal cortex in the modulation of basal and stress-induced autonomic output in rats,”Brain Res., 1996, 741, 220-229.
Griebel, G., et al., “Genetic differences in the mouse defense test battery,”Aggress. Behav., 1997, 23, 19-31.
Grigoriadis D.E., et al., “Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical chjaracterization and autoradiographic localization,”Peptides, 1989, 10, 179-188.
He, L., et al., “4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF1receptor,”J. Med. Chem., 2000, 43, 449-456.
Kobe, J., et al., “The chemistry of 4-hydrazino-7-phenylpyrazolo[1,5-a]-1,3,5-triazines,”J. Het. Chem., 1974, 991-996.
Kobe, J., et al., “The synthesis and chemical reactions of certain pyrazolo[1,5−a]-1,3,5-traizines(1),”J. Het. Chem., 1974, 199-204.
Meyers, A.I., et al., “An efficient total synthesis of propylure, the highly active sex attractant for the pink bollworm moth,”Tetrahedron, 1971, 27, 5979-5985.
Misslin, R., et al., “Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents,”Behav. Process, 1989, 18, 119-132.
Munson, P.J., et al., “LIGAND: A versatile computerized approach for characterization of ligand-binding systems,”Anal. Biochem., 1980, 107, 220-239.
Nagel, D.L., et al., “Synthesis of alkyl-substituted benzo[c]phenanthrenes and chrysenes by photocyclization,”J. Org. Chem., 1977, 42(22), 3626-3628.
Nishida, A., et al., “Rotational isomerism in fluorine derivatives XIV conformational equillbria of 62 -substituted 9-(2-cyanomethylphenyl) fluorine derivatives,”Technol. Rep. Yamaguchi Univ., 1988, 4(2), 145-150.
Novinson, T., et al., “synthesis of unsymmetrical 2,4-dialkylpyrazolo[1,5-a]-1,3,5-triazines,”J. Het. Chem., 1974, 691-695.
Pellow, S., et al., “Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat,”J. of Neurosci. Methods, 1985, 14, 149-167.
Page, G.A., et al., “The synthesis of benzcyclohepten-6-one,”J. Am. Chem. Soc., 1953, 75, 2053-2055.
Pietraszuk, C., et al., “Cross-metathesis of vinylsilanes with olefins in the presence of Grubbs'catalyst,”tetrahedron Lett., 2001, 1175-1178.
Porsolt, R.D., et al., “Depression: a new animal model sensitive to antidepressant treatment,”Nature, 1977, 266, 730-732.
Principles of Process Research and Chemical Development in the Pharmaceutical Industry,Wiley, 1998, p. 38-40.
Rapoport, H., et al., “The synthesis of 2,3,4-trimethoxybenzcyclohepten-6-one,”J. Am. Chem. Soc., 1951, 73, 2239-2241.
Senga, K., et al., “Synthesis and enzymic activity of various substituted pyrazolo[1,5-a]-1,3,5-triazines as adenosine cyclic 3′,5′-phosphate phosphodiesterase inhibitors,”J. Med. Chem., 1982, 25, 243-249.
Stogryn, E.L., “A new synthesis of 3,4-(difluoromethylenedioxy)benzaldehydr,”J. Org. Chem., 1972, 37(4), p. 673.
Vogel, J.R., et al., “A simple and reliable conflict procedure for testing anti-anxiety agents,”Psychopharmcologia(Berl.), 1971, 21, 1-7.
Willner, P., et al., “An animal model of anhedonia,”Clin. Neuropharmacol., 1992, 15 (supp. 1), 550A-551A.
Wynn, P.C., et al., “Regulation of corticotrophin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses,”Endocrinology, 1985, 116(4), 1653-1659.
McNulty Kenneth C.
Pack Shawn K.
Pesti Jaan A.
Sherbine James P.
Yule Robert E.
Balasubramanian Venkataraman
Bristol-Myers Squibb Pharma Company
Makujina Shah R.
Woodcock & Washburn LLP
LandOfFree
Processes for the preparation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Processes for the preparation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for the preparation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3776364